Cognition Therapeutics Inc. (CGTX) Statistics & Valuation Metrics - Stocknear

Cognition Therapeutics In...

NASDAQ: CGTX · Real-Time Price · USD
1.43
0.10 (7.52%)
At close: Sep 29, 2025, 3:59 PM
1.42
-0.70%
After-hours: Sep 29, 2025, 05:26 PM EDT

Cognition Therapeutics Statistics

Share Statistics

Cognition Therapeutics has 73.58M shares outstanding. The number of shares has increased by 54.47% in one year.

73.58M
54.47%
0.03%
18.81%
59.14M
18,464
0.16%

Short Selling Information

The latest short interest is 9M, so 10.2% of the outstanding shares have been sold short.

9M
10.2%
10.99%
1.88

Valuation Ratios

The PE ratio is -0.82 and the forward PE ratio is -4.5. Cognition Therapeutics's PEG ratio is 0.71.

-0.82
-4.5
0
5.2
1.49
-0.98
0.71
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cognition Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.04.

2.65
2.65
0.04
-0.02
-0.03
-2158.64

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.36M
25
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 216.06% in the last 52 weeks. The beta is 1.33, so Cognition Therapeutics's price volatility has been higher than the market average.

1.33
216.06%
1.56
0.75
38.77
11,378,977

Income Statement

n/a
-266K
-53.97M
-33.97M
-33.68M
-33.95M
-0.85
Full Income Statement

Balance Sheet

The company has 25.01M in cash and 814K in debt, giving a net cash position of 24.2M.

25.01M
814K
24.2M
-175.16M
19.62M
6.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.47M and capital expenditures -4K, giving a free cash flow of -28.48M.

-28.47M
-4K
-28.48M
-0.72
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

CGTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CGTX is $3, which is 125.6% higher than the current price. The consensus rating is "Buy".

$3
125.6%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-12.56
1